Skip to main content

News

Edward’s story: What happened after his Zolgensma gene therapy?

Edward’s story: What happened after his Zolgensma gene therapy?

29 August 2023

In 2021, when he was just eleven months old, Edward became one of the first patients in the UK to receive the potentially life-saving gene therapy, Zolgensma, at Sheffield Children’s. Now nearly three, Edward is “doing amazingly well”, said...

Read more...
Edward’s story: “the world is his oyster” after gene therapy treatment

Edward’s story: “the world is his oyster” after gene therapy treatment

11 August 2021

The mum of eleven month old Edward says “he has been given a future” after receiving gene-therapy for Spinal Muscular Atrophy. Baby Edward came to Sheffield Children’s to receive the potentially life-saving drug Zolgensma, which can prevent paralysis and...

Read more...
First patient in Yorkshire given potentially life-saving gene-therapy drug at Sheffield Children’s

First patient in Yorkshire given potentially life-saving gene-therapy drug at Sheffield Children’s

07 July 2021

A two month old baby is the first patient in Yorkshire to receive a potentially life-saving drug that can prevent paralysis and prolong the lives of children with Spinal Muscular Atrophy (SMA). Baby Markuss received the drug Zolgensma, which...

Read more...
ddd
Array
(
    [0] => Array
        (
            [message] => You currently have access to a subset of Twitter API v2 endpoints and limited v1.1 endpoints (e.g. media post, oauth) only. If you need access to this endpoint, you may need a different access level. You can learn more here: https://developer.twitter.com/en/portal/product
            [code] => 453
        )

)

By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close